» Articles » PMID: 30123436

Early Screening of Hypertension and Cardiac Dysautonomia in Each Hypertensive is Needed-inference from a Study of QTc Interval in Gujarat, India

Overview
Journal Int J Prev Med
Date 2018 Aug 21
PMID 30123436
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hypertension (HTN) is linked to cardiac dysautonomia that can end up as life-threatening arrhythmias. The same can be screened by simple electrocardiogram (ECG)-based QTc (QT corrected for heart rate) interval which indicates repolarization abnormality. We quantified QTc interval among treated hypertensives in comparison to controls, testing effect of age, gender, and blood pressure.

Methods: We conducted a cross-sectional study was done at a tertiary care teaching hospital of Gujarat, India, on 142 hypertensives on monotherapy (60 males, 82 females) and 72 age-, sex-, and time-matched normotensives. ECG was recorded with minimum 10 complexes of Lead II. QTc was derived from average of 10 values, using Bazett's formula. QTc > 0.43 s in male and > 0.45 s in female was considered abnormal.

Results: Hypertensives (mean age 40 and duration 5 years) had significantly higher QTc value than normotensives among males (0.42 vs. 0.40, < 0.001), females (0.44 vs. 0.41, < 0.001), and in total (0.43 vs. 0.41, < 0.001) with 24% prevalence of ECG-based left ventricular hypertrophy. Hypertensives had odds ratio 1.63 in males ( = 0.15), 23.71 in females ( = 0.003), and 3.83 in total ( < 0.001) for prolonged QTc. QTc values were significantly affected by increasing age amongst hypertensives but not by duration of HTN or current blood pressure.

Conclusions: Our study showed a high prevalence of prolonged QTc, both qualitatively and quantitatively, in hypertensives on monotherapy with poor pressure control, associated with female gender and age but not duration or blood pressure. This underscores high risk of repolarization abnormality induced future event, suggesting QTc screening as primary prevention.

Citing Articles

Arterial stiffness is associated with prehypertension in both non-hypertensives and treated hypertensives-A matched case control study.

Solanki J, Vohra A, Hirani C, Bhatt D Indian Heart J. 2024; 76(3):224-228.

PMID: 38871217 PMC: 11329018. DOI: 10.1016/j.ihj.2024.06.007.


Prevalence and Risk Factors of Hypertension in Schoolchildren from Central Thailand: A Cross-Sectional Study.

Rerksuppaphol L, Rerksuppaphol S Int J Prev Med. 2021; 12:28.

PMID: 34249277 PMC: 8218803. DOI: 10.4103/ijpvm.IJPVM_110_20.


Assessment of Hypertension Using Clinical Electrocardiogram Features: A First-Ever Review.

Bird K, Chan G, Lu H, Greeff H, Allen J, Abbott D Front Med (Lausanne). 2020; 7:583331.

PMID: 33344473 PMC: 7746856. DOI: 10.3389/fmed.2020.583331.


Acquired long QT syndrome in chronic kidney disease patients.

Liu P, Wang L, Han D, Sun C, Xue X, Li G Ren Fail. 2019; 42(1):54-65.

PMID: 31878817 PMC: 6968512. DOI: 10.1080/0886022X.2019.1707098.


Prevalence of Hypertension in Renal Diseases in Iran: Systematic Review and Meta-Analysis.

Motedayen M, Sarokhani D, Ghiasi B, Khatony A, Hasanpour Dehkordi A Int J Prev Med. 2019; 10:124.

PMID: 31367287 PMC: 6639851. DOI: 10.4103/ijpvm.IJPVM_522_18.

References
1.
Greenland P, Alpert J, Beller G, Benjamin E, Budoff M, Fayad Z . 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010; 122(25):e584-636. DOI: 10.1161/CIR.0b013e3182051b4c. View

2.
Francis J . Prevention of sudden cardiac death. Indian Pacing Electrophysiol J. 2011; 11(4):91-2. PMC: 3128814. View

3.
Madhavan S, Reddy S, Panuganti P, Joshi R, Mallidi J, Raju K . Epidemiology of sudden cardiac death in rural South India - insights from the andhra pradesh rural health initiative. Indian Pacing Electrophysiol J. 2011; 11(4):93-102. PMC: 3128815. View

4.
Lieb W, Enserro D, Sullivan L, Vasan R . Residual Cardiovascular Risk in Individuals on Blood Pressure-Lowering Treatment. J Am Heart Assoc. 2015; 4(11). PMC: 4845218. DOI: 10.1161/JAHA.115.002155. View

5.
Wang J, Li Y, Franklin S, Safar M . Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers: a quantitative overview. Hypertension. 2007; 50(1):181-8. DOI: 10.1161/HYPERTENSIONAHA.107.089763. View